QSS
BSX icon

Quantitative Systematic Strategies’s Boston Scientific BSX Stock Holding History

Quantitative Systematic Strategies’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-76,369
Closed -$2.75M – 622
2020
Q4 		$2.75M Sell
76,369
-21,174
-22% -$763K 0.39% 59
2020
Q3 		$3.73M Buy
97,543
+12,652
+15% +$488K 0.65% 19
2020
Q2 		$2.98M Buy
84,891
+33,668
+66% +$1.21M 0.59% 20
2020
Q1 		$1.67M Sell
51,223
-83,012
-62% -$3.24M 1.37% 6
2019
Q4 		$6.07M Buy
134,235
+63,870
+91% +$2.67M 0.89% 4
2019
Q3 		$2.86M Buy
70,365
+27,742
+65% +$1.18M 0.66% 35
2019
Q2 		$1.83M Buy
42,623
+63
+0.1% +$2.42K 0.35% 96
2019
Q1 		$1.63M Sell
42,560
-964
-2% -$36.8K 0.4% 84
2018
Q4 		$1.54M Buy
43,524
+472
+1% +$17.1K 0.34% 85
2018
Q3 		$1.66M Buy
43,052
+4,411
+11% +$154K 0.32% 97
2018
Q2 		$1.26M Sell
38,641
-35,855
-48% -$1.08M 0.23% 141
2018
Q1 		$2.04M Sell
74,496
-25,208
-25% -$685K 0.43% 42
2017
Q4 		$2.47M Buy
99,704
+31,390
+46% +$866K 0.63% 11
2017
Q3 		$1.99M Sell
68,314
-17,195
-20% -$475K 0.53% 49
2017
Q2 		$2.38M Sell
85,509
-22,236
-21% -$590K 0.6% 35
2017
Q1 		$2.68M Buy
107,745
+24,228
+29% +$589K 0.75% 16
2016
Q4 		$1.81M Sell
83,517
-11,548
-12% -$252K 0.74% 14
2016
Q3 		$2.22M Buy
95,065
+22,906
+32% +$546K 0.81% 11
2016
Q2 		$1.66M Buy
72,159
+32,448
+82% +$702K 0.78% 4
2016
Q1 		$747K Sell
39,711
-6,365
-14% -$112K 0.29% 143
2015
Q4 		$857K Buy
46,076
+20,759
+82% +$372K 0.23% 75
2015
Q3 		$415K Buy
25,317
+2,858
+13% +$48.9K 0.2% 190
2015
Q2 		$400K Sell
22,459
-10,020
-31% -$179K 0.09% 357
2015
Q1 		$587K Buy
32,479
+17,093
+111% +$270K 0.16% 182
2014
Q4 		$205K Buy
15,386
+3,512
+30% +$44.9K 0.08% 279
2014
Q3 		$141K Sell
11,874
-19,883
-63% -$250K 0.08% 282
2014
Q2 		$405K Buy
31,757
+6,374
+25% +$82.9K 0.29% 140
2014
Q1 		$338K Buy
+25,383
New +$333K 0.28% 166

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Quantitative Systematic Strategies's BSX Position: Q1 2021 in Review

Quantitative Systematic Strategies sold out of Boston Scientific (BSX) in Q1 2021, closing a stake of 76,369 shares — an estimated $2.75M sold.

Quantitative Systematic Strategies first reported a position in BSX in Q1 2014 and held it in 28 quarters. The position peaked at $6.07M in Q4 2019. 832 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

  • Quantitative Systematic Strategies reported no remaining Boston Scientific position as of Q1 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 76,369 Boston Scientific shares in Q1 2021, an estimated $2.75M.
  • Quantitative Systematic Strategies first reported a position in Boston Scientific in Q1 2014 and held it in 28 quarters.
  • Quantitative Systematic Strategies's Boston Scientific position peaked at $6.07M in Q4 2019.
  • 832 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2021, filed 6 May 2021.